Shares of CSL Limited (OTCMKTS:CSLLY – Get Free Report) reached a new 52-week low during trading on Friday . The company traded as low as $83.31 and last traded at $86.54, with a volume of 75792 shares. The stock had previously closed at $86.47.
CSL Stock Performance
The firm has a 50-day moving average of $93.02 and a two-hundred day moving average of $97.72. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97.
About CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Articles
- Five stocks we like better than CSL
- Election Stocks: How Elections Affect the Stock Market
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Investing In Automotive Stocks
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What is a Death Cross in Stocks?
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
